RAYMOND JAMES & ASSOCIATES - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 305 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$342,375
-64.0%
8,250
-47.9%
0.00%
-100.0%
Q1 2023$951,895
-21.6%
15,828
-4.4%
0.00%0.0%
Q4 2022$1,214,236
-9.7%
16,554
-6.4%
0.00%0.0%
Q3 2022$1,344,000
+4.6%
17,694
-4.3%
0.00%0.0%
Q2 2022$1,285,000
-28.9%
18,486
-15.3%
0.00%
-50.0%
Q1 2022$1,807,000
+6.2%
21,813
-3.8%
0.00%
+100.0%
Q4 2021$1,702,000
-23.7%
22,667
+18.0%
0.00%
-50.0%
Q3 2021$2,231,000
-45.3%
19,204
+4.5%
0.00%
-50.0%
Q2 2021$4,077,000
+85.7%
18,380
+10.7%
0.00%
+100.0%
Q1 2021$2,195,000
-77.7%
16,603
-70.8%
0.00%
-81.8%
Q4 2020$9,832,000
+365.3%
56,818
+199.3%
0.01%
+266.7%
Q3 2020$2,113,000
+44.2%
18,982
-23.2%
0.00%
+50.0%
Q2 2020$1,465,000
+26.8%
24,708
+44.0%
0.00%0.0%
Q1 2020$1,155,000
-26.5%
17,158
-7.9%
0.00%0.0%
Q4 2019$1,571,000
+33.5%
18,637
+18.4%
0.00%0.0%
Q3 2019$1,177,000
+264.4%
15,740
+208.4%
0.00%
Q2 2019$323,000
+36.9%
5,103
+4.1%
0.00%
Q1 2019$236,000
-0.8%
4,902
-31.1%
0.00%
Q4 2018$238,000
-15.9%
7,113
+31.7%
0.00%
Q3 2018$283,0005,3990.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders